Dendritic Cells : Key to Cancer Immunotherapy | Zendy

Kimia Alizadeh | Zendy; Kasra Alizadeh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dendritic Cells : Key to Cancer Immunotherapy

Author(s) -

Kimia Alizadeh,

Kasra Alizadeh

Publication year - 2017

Publication title -

the cancer press

Language(s) - English

Resource type - Journals

ISSN - 2476-3748

DOI - 10.15562/tcp.37

Subject(s) - cancer immunotherapy , key (lock) , immunotherapy , cancer , medicine , biology , ecology

www.thecancerpress.com Corresponding Author E-Mail: k.alizadeh95@gmail.com 6 References 1. Appay V, Douek DC, Price DA. CD8+ T cell efficacy in vaccination and disease. Nat Med. 2008;14(6):623-8. 2. Ariizumi K, Shen G-L, Shikano S, Xu S, Ritter R, Kumamoto T, et al. Identification of a Novel, Dendritic Cellassociated Molecule, Dectin-1, by Subtractive cDNA Cloning. Journal of Biological Chemistry. 2000;275 (26):20157-67. 3. Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E. Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors. The Journal of Experimental Medicine. 1997;186(7):1177-82. Vol 3, No 1, March, 2017, P 6-12 DOI, 10.15562/tcp.37 Review Paper Vol. 3, No.1, March, 2017

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research